Dermatophagoides pteronyssinus

also known as Alutard SQ

Developed for: perennial allergic rhinitis · allergic rhinitis
Investigated by: National Research Council of Thailand · Pongsakorn Tantilipikorn

today NCT01115595 · Ph 4

201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT01115595	Mar 2010 → Oct 2013	perennial allergic rhinitis	Pongsakorn Tantilipikorn	Completed	No outcome recorded

Also used as a comparator or background therapy in 2 trials

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
—	NCT05450289 Background	Aug 2022 → Mar 2023	house allergic alveolitis	Universitas Airlangga	Unknown	No outcome recorded
—	NCT01291381 Comparator	Feb 2009 → Feb 2010	allergic rhinitis	Beijing Tongren Hospital	Completed	No outcome recorded

Every value below carries the sentence it was read from. 3 sources stand behind the page.

Field	Value	Cited text
Known as	Dermatophagoides pteronyssinus	“extract of Dermatophagoides pteronyssinus via subcutaneous injection.” NCT05450289 ↗ 2 “Dermatophagoides pteronyssinus from ALK company” NCT01115595 ↗ NCT01291381 ↗
Known as	Alutard SQ	“Children undergoing subcutaneous immunotherapy were given Dermatophagoides pteronyssinus extract (Alutard SQ, ALK-Abello, Hørsholm, Denmark) according to a cluster protocol” NCT01291381 ↗
Route	Other	“injection by Mite extract” NCT01115595 ↗